Status:
COMPLETED
Treatment Trial for Post-Thrombotic Syndrome
Lead Sponsor:
University of Vermont
Conditions:
Post Thrombotic Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.
Detailed Description
Post thrombotic syndrome (PTS) has a spectrum of disease manifestations ranging from minor skin discoloration to severe skin changes and venous ulcerations. Pain is often a prominent symptoms and PTS ...
Eligibility Criteria
Inclusion
- Age \>18 years.
- Diagnosis of post thrombotic syndrome.
- Median life expectancy of greater than 2 years.
- Previous history of lower extremity deep venous thrombosis.
Exclusion
- Acute venous thrombosis of the lower extremity within the last 180 days.
- Unable to participate in lymphedema therapy due to monetary, physical or transportation limitations.
- Uncontrolled illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
- Pregnant women and women in their first post-partum month.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00633971
Start Date
March 1 2008
End Date
September 1 2011
Last Update
September 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fletcher Allen Health Care; Department of Hematology/Oncology
Burlington, Vermont, United States, 05401